Low data variability

Our core ECG laboratory provides a centralised system for all our studies. High precision ECG acquisition in our clinic provides meaningful ECG analysis with a smaller sample size, making us the ideal choice for the integration of cardiac safety in FIH and MAD studies.

We are a leading publisher in cardiology and have publicly accessible credentials. We are proud of our integrity, our professional growth and experience in this field.

Learn more about our ECG Lab

Exceptional ECG generation

We undertake and analyse several cardiological assessments using state-of-the-art equipment to understand and explain abnormal ECG data obtained during a clinical study of a new chemical entity.

Learn more about our Cardio Analysis Services

Experts in cardiac safety

Richmond Pharmacology’s Core ECG Laboratory team are based within St George’s Hospital Medical School, London and are made up of highly experienced cardiologists headed by Professor John Camm, a key opinion leader in TQT Trials.

Learn more about our expert cardiologists

Transforming clinical trials to accelerate drug development – Keith Berelowitz

23
August 2022

Dr Keith Berelowitz, Richmond Pharmacology’s Director of Operations, wrote recently for Pharmaceutical Market Europe where he outlined how innovations in the design and delivery of clinical trials are speeding up the discovery of new therapies for the benefit of patients, sponsors and health systems.

View article

Clinical trials and the patient perspective

6
May 2022

Successful recruitment and retention of patients - an essential element to delivering clinical studies on time.

View article

Clinical trials: how taking the pills can pay those bills.

20
April 2022

The Guardian references Richmond Pharmacology in feature on reimbursement for clinical trial volunteers

View article

How the innovative use of data is transforming clinical research

2
March 2022

Dr. Dilshat Djumanov, Director of Data Science at Richmond Pharmacology, outlined the evolution of data management in clinical research and how this aids faster results and greater efficiencies.

View article

NTLA-2001 demonstrates positive results for Intellia Therapeutics and Regeneron Pharmaceuticals

2
March 2022

The latest interim data released indicates a promising future for ATTR patients.

View article

The future of clinical workforce training programmes, an exclusive interview with MedCity

30
November 2021

Ulrike Lorch discusses the future of clinical workforce training programmes in an exclusive interview with MedCity

View article

Latest news

Futureproofing early phase clinical research for the next generation of investigators.

March 20, 2023
Richmond Pharmacology’s experienced Principal investigators and Co-investigators recently gave expert feedback on the ICH M11 (CeSHarP) protocol template.
Read more

Director of Operations, Keith Berelowitz, has been appointed as the Research Ethics Committee Chair for the Health Research Authority.

January 19, 2023
Keith Berelowitz will be responsible for ensuring that all ethical possibilities are explored in relation to new research.
Read more

Events

13th International Workshop on Regulatory Requirements and Current Scientific Aspects on the Preclinical and Clinical Investigation of Drug-Drug Interactions

Sunday, June 4th to Tuesday June 6th 2023
Exchange research-based knowledge on drug-drug interactions (DDIs) among all interested stakeholders from pharmaceutical industry, regulatory authorities, academic and health care delivery backgrounds and perspectives.
View event